KIT exon 13 mutation
|
Melanoma
|
KIT exon 13 mutation
|
Melanoma
|
sunitinib Sensitive: A2 - Guideline
|
sunitinib Sensitive: A2 - Guideline
|
KIT exon 13 mutation
|
Melanoma
|
KIT exon 13 mutation
|
Melanoma
|
nilotinib Sensitive: A2 - Guideline
|
nilotinib Sensitive: A2 - Guideline
|
KIT exon 13 mutation
|
Melanoma
|
KIT exon 13 mutation
|
Melanoma
|
imatinib Sensitive: B - Late Trials
|
imatinib Sensitive: B - Late Trials
|
KIT exon 13 mutation
|
GIST
|
KIT exon 13 mutation
|
GIST
|
ripretinib Sensitive: B - Late Trials
|
ripretinib Sensitive: B - Late Trials
|
KIT exon 13 mutation
|
GIST
|
KIT exon 13 mutation
|
GIST
|
regorafenib Sensitive: B - Late Trials
|
regorafenib Sensitive: B - Late Trials
|